Stock Scorecard
Stock Summary for Bausch Health Companies Inc (BHC) - $5.61 as of 5/21/2026 7:11:30 PM EST
Total Score
10 out of 30
Safety Score
26 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for BHC
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for BHC
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for BHC
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for BHC
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for BHC (26 out of 100)
| Stock Price Rating (Max of 10) | 4 |
| Historical Stock Price Rating (Max of 10) | 4 |
| Stock Price Trend (Max of 10) | 0 |
| Book Value (Max of 10) | 1 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 0 |
| Analyst Strong Buy Ratings (Max of 5) | 3 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 5 |
| Trading Volume (Max of 10) | 9 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for BHC
Financial Details for BHC
Company Overview |
|
|---|---|
| Ticker | BHC |
| Company Name | Bausch Health Companies Inc |
| Country | USA |
| Description | Bausch Health Companies Inc. develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology and dermatology. The company is headquartered in Laval, Canada. |
| Sector Name | HEALTHCARE |
| Industry Name | DRUG MANUFACTURERS - SPECIALTY & GENERIC |
| Most Recent Quarter | 3/31/2026 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 5.61 |
| Price 4 Years Ago | 6.28 |
| Last Day Price Updated | 5/21/2026 7:11:30 PM EST |
| Last Day Volume | 1,854,721 |
| Average Daily Volume | 1,660,768 |
| 52-Week High | 8.69 |
| 52-Week Low | 4.41 |
| Last Price to 52 Week Low | 27.21% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 60.55 |
| Sector PE | 102.03 |
| 5-Year Average PE | 3.25 |
| Free Cash Flow Ratio | 1.61 |
| Industry Free Cash Flow Ratio | 16.15 |
| Sector Free Cash Flow Ratio | 32.46 |
| Current Ratio Most Recent Quarter | 1.32 |
| Total Cash Per Share | 3.48 |
| Book Value Per Share Most Recent Quarter | -5.51 |
| Price to Book Ratio | 18.78 |
| Industry Price to Book Ratio | 17.71 |
| Sector Price to Book Ratio | 7.66 |
| Price to Sales Ratio Twelve Trailing Months | 0.20 |
| Industry Price to Sales Ratio Twelve Trailing Months | 4.90 |
| Sector Price to Sales Ratio Twelve Trailing Months | 25.43 |
| Analyst Buy Ratings | 0 |
| Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
| Total Shares Outstanding | 373,476,000 |
| Market Capitalization | 2,095,200,360 |
| Institutional Ownership | 65.11% |
Dividends |
|
| Ex-Dividend Date | 11/10/2010 |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 1.0000 |
| Total Years Dividend Increasing | 0 |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 5.11 |
| Forward Annual Dividend Yield | 68.43% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 1,328.57% |
| 3-Year Dividend Growth Rate Percentage | 149.03% |
| 5-Year Dividend Growth Rate Percentage | 27.79% |
| All-Time Dividend Growth Rate Percentage | -10.95% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 1,368.00% |
| Annual Earnings Growth | 447.28% |
| Reported EPS 12 Trailing Months | -3.24 |
| Reported EPS Past Year | 0.78 |
| Reported EPS Prior Year | 3.09 |
| Net Income Twelve Trailing Months | -1,189,488,348 |
| Net Income Past Year | 159,748,368 |
| Net Income Prior Year | -46,000,000 |
| Quarterly Revenue Growth YOY | 11.70% |
| 5-Year Revenue Growth | 5.41% |
| Operating Margin Twelve Trailing Months | 20.60% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 1,299,000,000 |
| Total Cash Past Year | 1,322,588,698 |
| Total Cash Prior Year | 1,181,000,000 |
| Net Cash Position Most Recent Quarter | -18,576,000,000 |
| Net Cash Position Past Year | -19,269,411,302 |
| Long Term Debt Past Year | 20,592,000,000 |
| Long Term Debt Prior Year | 18,942,000,000 |
| Total Debt Most Recent Quarter | 19,875,000,000 |
| Equity to Debt Ratio Past Year | -0.03 |
| Equity to Debt Ratio Most Recent Quarter | -0.12 |
| Total Stockholder Equity Past Year | -552,991,803 |
| Total Stockholder Equity Prior Year | -1,279,000,000 |
| Total Stockholder Equity Most Recent Quarter | -2,059,000,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 989,528,228 |
| Free Cash Flow Per Share Twelve Trailing Months | 2.65 |
| Free Cash Flow Past Year | 1,003,000,000 |
| Free Cash Flow Prior Year | 1,260,000,000 |
Options |
|
| Put/Call Ratio | 0.10 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.08 |
| MACD Signal | 0.07 |
| 20-Day Bollinger Lower Band | 4.50 |
| 20-Day Bollinger Middle Band | 5.98 |
| 20-Day Bollinger Upper Band | 7.47 |
| Beta | 0.42 |
| RSI | 51.92 |
| 50-Day SMA | 6.23 |
| 150-Day SMA | 7.14 |
| 200-Day SMA | 7.18 |
System |
|
| Modified | 5/21/2026 6:35:16 PM EST |